These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 25733524)
1. Escherichia coli EDL933 requires gluconeogenic nutrients to successfully colonize the intestines of streptomycin-treated mice precolonized with E. coli Nissle 1917. Schinner SA; Mokszycki ME; Adediran J; Leatham-Jensen M; Conway T; Cohen PS Infect Immun; 2015 May; 83(5):1983-91. PubMed ID: 25733524 [TBL] [Abstract][Full Text] [Related]
2. Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine. Miranda RL; Conway T; Leatham MP; Chang DE; Norris WE; Allen JH; Stevenson SJ; Laux DC; Cohen PS Infect Immun; 2004 Mar; 72(3):1666-76. PubMed ID: 14977974 [TBL] [Abstract][Full Text] [Related]
3. Precolonized human commensal Escherichia coli strains serve as a barrier to E. coli O157:H7 growth in the streptomycin-treated mouse intestine. Leatham MP; Banerjee S; Autieri SM; Mercado-Lubo R; Conway T; Cohen PS Infect Immun; 2009 Jul; 77(7):2876-86. PubMed ID: 19364832 [TBL] [Abstract][Full Text] [Related]
4. Nutritional basis for colonization resistance by human commensal Escherichia coli strains HS and Nissle 1917 against E. coli O157:H7 in the mouse intestine. Maltby R; Leatham-Jensen MP; Gibson T; Cohen PS; Conway T PLoS One; 2013; 8(1):e53957. PubMed ID: 23349773 [TBL] [Abstract][Full Text] [Related]
5. An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic. Adediran J; Leatham-Jensen MP; Mokszycki ME; Frimodt-Møller J; Krogfelt KA; Kazmierczak K; Kenney LJ; Conway T; Cohen PS Infect Immun; 2014 Feb; 82(2):670-82. PubMed ID: 24478082 [TBL] [Abstract][Full Text] [Related]
6. Comparison of carbon nutrition for pathogenic and commensal Escherichia coli strains in the mouse intestine. Fabich AJ; Jones SA; Chowdhury FZ; Cernosek A; Anderson A; Smalley D; McHargue JW; Hightower GA; Smith JT; Autieri SM; Leatham MP; Lins JJ; Allen RL; Laux DC; Cohen PS; Conway T Infect Immun; 2008 Mar; 76(3):1143-52. PubMed ID: 18180286 [TBL] [Abstract][Full Text] [Related]
8. Treatment of inflammatory bowel disease associated E. coli with ciprofloxacin and E. coli Nissle in the streptomycin-treated mouse intestine. Petersen AM; Schjørring S; Gerstrøm SC; Krogfelt KA PLoS One; 2011; 6(8):e22823. PubMed ID: 21853049 [TBL] [Abstract][Full Text] [Related]
9. L-fucose stimulates utilization of D-ribose by Escherichia coli MG1655 DeltafucAO and E. coli Nissle 1917 DeltafucAO mutants in the mouse intestine and in M9 minimal medium. Autieri SM; Lins JJ; Leatham MP; Laux DC; Conway T; Cohen PS Infect Immun; 2007 Nov; 75(11):5465-75. PubMed ID: 17709419 [TBL] [Abstract][Full Text] [Related]
10. The gluconeogenesis pathway is involved in maintenance of enterohaemorrhagic Escherichia coli O157:H7 in bovine intestinal content. Bertin Y; Deval C; de la Foye A; Masson L; Gannon V; Harel J; Martin C; Desvaux M; Forano E PLoS One; 2014; 9(6):e98367. PubMed ID: 24887187 [TBL] [Abstract][Full Text] [Related]
11. Overexpressed Proteins in Hypervirulent Clade 8 and Clade 6 Strains of Escherichia coli O157:H7 Compared to E. coli O157:H7 EDL933 Clade 3 Strain. Amigo N; Zhang Q; Amadio A; Zhang Q; Silva WM; Cui B; Chen Z; Larzabal M; Bei J; Cataldi A PLoS One; 2016; 11(11):e0166883. PubMed ID: 27880834 [TBL] [Abstract][Full Text] [Related]
12. Probiotic Properties of Escherichia coli Nissle in Human Intestinal Organoids. Pradhan S; Weiss AA mBio; 2020 Jul; 11(4):. PubMed ID: 32636253 [No Abstract] [Full Text] [Related]
13. Genomic peculiarity of coding sequences and metabolic potential of probiotic Escherichia coli strain Nissle 1917 inferred from raw genome data. Sun J; Gunzer F; Westendorf AM; Buer J; Scharfe M; Jarek M; Gössling F; Blöcker H; Zeng AP J Biotechnol; 2005 May; 117(2):147-61. PubMed ID: 15823404 [TBL] [Abstract][Full Text] [Related]
14. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7. Rund SA; Rohde H; Sonnenborn U; Oelschlaeger TA Int J Med Microbiol; 2013 Jan; 303(1):1-8. PubMed ID: 23312798 [TBL] [Abstract][Full Text] [Related]
15. The streptomycin-treated mouse intestine selects Escherichia coli envZ missense mutants that interact with dense and diverse intestinal microbiota. Leatham-Jensen MP; Frimodt-Møller J; Adediran J; Mokszycki ME; Banner ME; Caughron JE; Krogfelt KA; Conway T; Cohen PS Infect Immun; 2012 May; 80(5):1716-27. PubMed ID: 22392928 [TBL] [Abstract][Full Text] [Related]
16. Coculture of Escherichia coli O157:H7 with a Nonpathogenic E. coli Strain Increases Toxin Production and Virulence in a Germfree Mouse Model. Goswami K; Chen C; Xiaoli L; Eaton KA; Dudley EG Infect Immun; 2015 Nov; 83(11):4185-93. PubMed ID: 26259815 [TBL] [Abstract][Full Text] [Related]
17. Global expression of prophage genes in Escherichia coli O157:H7 strain EDL933 in response to norfloxacin. Herold S; Siebert J; Huber A; Schmidt H Antimicrob Agents Chemother; 2005 Mar; 49(3):931-44. PubMed ID: 15728886 [TBL] [Abstract][Full Text] [Related]
18. The Life of Commensal Escherichia coli in the Mammalian Intestine. Conway T; Krogfelt KA; Cohen PS EcoSal Plus; 2004 Dec; 1(1):. PubMed ID: 26443354 [TBL] [Abstract][Full Text] [Related]
19. Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron. Deriu E; Liu JZ; Pezeshki M; Edwards RA; Ochoa RJ; Contreras H; Libby SJ; Fang FC; Raffatellu M Cell Host Microbe; 2013 Jul; 14(1):26-37. PubMed ID: 23870311 [TBL] [Abstract][Full Text] [Related]
20. An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine. Møller AK; Leatham MP; Conway T; Nuijten PJ; de Haan LA; Krogfelt KA; Cohen PS Infect Immun; 2003 Apr; 71(4):2142-52. PubMed ID: 12654836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]